Hostname: page-component-7dd5485656-zklqj Total loading time: 0 Render date: 2025-10-31T16:11:37.611Z Has data issue: false hasContentIssue false
  • English
  • Français

Oxytocin and Vasopressin: Social Neuropeptides

Published online by Cambridge University Press:  07 November 2014

Dan J. Stein
Get access Rights & Permissions [Opens in a new window]

Abstract

Oxytocin and vasopressin are highly conserved neuropeptides that play a key role in social attachment and affiliation, including parental care and pair-bonding. Oxytocin attenuates neural responses to aversive pictures and has been associated with reduced coupling of amygdala to brainstem regions involved in the fear response. Differential activation of the amygdala has been found to be associated with different genetic variants of the vasopressin receptor. There is growing evidence that oxytocin and vasopressin receptor variants are associated with individual differences in prosocial behavior. It is humbling that differences in complex human behaviors may be partially explicable on the basis of relatively simple neuropeptide systems. Nevertheless, such findings potentially allow for targeted interventions for a range of psychiatric disorders in which such systems play a role.

Information

Type
Pearls in Clinical Neuroscience
Information
CNS Spectrums , Volume 14 , Issue 11 , November 2009 , pp. 602 - 606
Copyright
Copyright © Cambridge University Press 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

REFERENCES

1.Heinrichs, M, Domes, G. Neuropeptides and social behaviour: effects of oxytocin and vasopressin in humans. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:337–350.Google Scholar
2.Lee, HJ, Macbeth, AH, Pagani, JH, Young, WS 3rd. Oxytocin: The great facilitator of life. Prog Neurobiol. 2009;88:127–151.Google Scholar
3.Ebstein, RP, Israel, S, Lerer, E, et al.Arginine Vasopressin and Oxytocin Modulate Human Social Behavior. Ann N Y Acad Sci. 2009;1167:87–102.Google Scholar
4.Insel, TR. A neurobiological basis of social attachment. Am J Psychiatry. 1997;154:726–735.Google ScholarPubMed
5.Bora, E, Yucel, M, Allen, NB. Neurobiology of human affiliative behaviour: implications for psychiatric disorders. Curr Opin Psychiatry. 2009;22:320–325.Google Scholar
6.Donaldson, ZR, Young, LJ. Oxytocin, Vasopressin, and the Neurogenetics of Sociality. Science. 2008;322:900–904.Google Scholar
7.Heinrichs, M, Baumgartner, T, Kirschbaum, C, Ehlert, U. Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry. 2003;54:1389–1398.Google Scholar
8.Thompson, RR, George, K, Walton, JC. Orr, SP, Benson, J. Sex-specific influences of vasopressin on human social communication. Proc Natl Acad Sci USA. 2006;103:7889–7894.Google Scholar
9.Insel, TR. Is social attachment an addictive disorder? Physiol Behav. 2003;79:351–357.Google Scholar
10.Hammock, EAD, Young, LJ. Oxytocin, vasopressin and pair bonding: implications for autism. Philos Trans R Soc B Biol Sci. 2006;361:2187–2198.CrossRefGoogle ScholarPubMed
11.Marazziti, D, Dell'Osso, MC. The role of oxytocin in neuropsychiatric disorders. Curr Med Chem. 2008;15:698–704.Google Scholar
12.Leckman, JF, Goodman, WK, North, WG, et al.The role of central oxytocin in obsessive compulsive disorder and related normal behavior. Psychoneuroendocrinology. 1994;19:723–749.Google Scholar
13.Meyer-Lindenberg, A. Impact of prosocial neuropeptides on human brain function. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:463–470.Google Scholar
14.Israel, S, Lerer, E, Shalev, I, et al.Molecular genetic studies of the arginine vasopressin 1a receptor (AVPR1a) and the oxytocin receptor (OXTR) in human behaviour: from autism to altruism with some notes in between. In: Landgraf, R. Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:435–449.Google Scholar
15.Carter, CS. Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? Behav Brain Res. 2007;176:170–186.Google Scholar
16.Heinrichs, M, von Dawans, B, Domes, G. Oxytocin, vasopressin, and human social behavior. Front Neuroendocrinol. 2009;30:548–557.Google Scholar
17.de Vries, GJ. Sex differences in vasopressin and oxytocin innervation of the brain. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:17–27.Google Scholar
18.Huber, D, Veinante, P, Stoop, R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science. 2005;308:245–248.CrossRefGoogle ScholarPubMed
19.Viviani, D, Stoop, R. Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:207–218.Google Scholar
20.Ferris, CF. Functional magnetic resonance imaging and the neurobiology of vasopressin and oxytocin. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:305–320.Google Scholar
21.Febo, M, Ferris, CF. Functional imaging reveals maternal brain circuitry responsive to suckling and oxytocin in the lactating rat. Hormones and Behavior. 2005;48:92.Google Scholar
22.Kosfeld, M, Heinrichs, M, Zak, PJ, Fischbacher, U, Fehr, E. Oxytocin increases trust in humans. Nature. 2005;435:673–676.Google Scholar
23.Domes, G, Heinrichs, M, Michel, A, Berger, C, Herpertz, SC. Oxytocin improves “mindreading” in humans. Biol Psychiatry. 2007;61:731–733.CrossRefGoogle ScholarPubMed
24.Kirsch, P, Esslinger, C, Chen, Q, et al.Oxytocin modulates neural circuitry for social cognition and fear in humans. J Neurosci. 2005;25:11489–11493.CrossRefGoogle ScholarPubMed
25.Domes, G, Heinrichs, M, Glascher, J, Buchel, C, Braus, DF, Herpertz, SC. Oxytocin attenuates amygdala responses to emotional faces regardless of valence. Biol Psychiatry. 2007;62:1187–1190.Google Scholar
26.Baumgartner, T, Heinrichs, M, Vonlanthen, A, Fischbacher, U, Fehr, E. Oxytocin shapes the neural circuitry of trust and trust adaptation in humans. Neuron. 2008;58:639–650.CrossRefGoogle ScholarPubMed
27.Petrovic, P, Kalisch, R, Singer, T, Dolan, RJ. Oxytocin attenuates affective evaluations of conditioned faces and amygdala activity. J Neurosci. 2008;28:6607–6615.Google Scholar
28.Domes, G, Lischke, A, Berger, C, et al.Effects of intranasal oxytocin on emotional face processing in women. Psychoneuroendocrinology. In press.Google Scholar
29.Meyer-Lindenberg, A, Kolachana, B, Gold, B, et al.Genetic variants in AVPR1A linked to autism predict amygdala activation and personality traits in healthy humans. Mol Psychiatry. 2009;14:968–975.Google Scholar
30.Pitman, RK, Orr, SP, Lasko, NB. Effects of Intranasal Vasopressin and Oxytocin on Physiological Responding During Personal Combat Imagery in Vietnam Veterans with Posttraumatic-Stress-Disorder. Psychiatry Res. 1993;48:107–117.Google Scholar
31.McGregor, IS, Callaghan, PD, Hunt, GE. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? Br J Pharmacol. 2008;154:358–368.CrossRefGoogle ScholarPubMed
32.Dempster, EL, Burcescu, I, Wigg, K, et al.Evidence of an association between the vasopressin V1b receptor gene (AVPR1 B) and childhood-onset mood disorders. Arch Gen Psychiatry. 2007;64:1189–1195.Google Scholar
33.Goldman, M, Marlow-O'Connor, M, Torres, I, Carter, CS. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res. 2008;98:247–255.Google Scholar
34.Thompson, MR, Callaghan, PD, Hunt, GE, Cornish, JL, McGregor, IS. A role for oxytocin and 5-HT1A receptors in the prosocial effects of 3, 4-methylenedioxymetham-phetamine (“ecstasy”). Neuroscience. 2007;146:509–514.Google Scholar
35.Enck, P, Klosterhalfen, S. The story of O–is oxytocin the mediator of the placebo response? Neurogastroenterol Motil. 2009;21:347–350.Google Scholar
36.Knafo, A, Plomin, R. Prosocial behavior from early to middle childhood: Genetic and environmental influences on stability and change. Dev Psychol. 2006;42:771–786.Google Scholar
37.Brunton, PJ, Russell, JA. Keeping oxytocin neurons under control during stress in pregnancy. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:365–377.Google Scholar
38.Israel, S, Lerer, E, Shalev, I, et al.The oxytocin receptor contributes to prosocial fund allocations in the dictator game and the social value orientations task. PLoS One. 2009;4:e5535.Google Scholar
39.Walum, H, Westberg, L, Henningsson, S, et al.Genetic variation in the vasopressin receptor la gene (AVPR1A) associates with pair-bonding behavior in humans. Proc Natl Acad Sci USA. 2008;105:14153–14156.Google Scholar
40.Winslow, JT, Shapiro, L, Carter, CS, Insel, TR. Oxytocin and complex social-behavior - species comparisons. Psychopharmacol Bull. 1993;29:409–414.Google Scholar
41.Insel, TR, Shapiro, LE. Oxytocin Receptor Distribution Reflects Social-Organization in Monogamous and Polygamous Voles. Proc Natl Acad Sci USA. 1992;89:5981–5985.Google Scholar
42.Hammock, EAD, Young, LJ. Variation in the vasopressin V1a receptor promoter and expression: implications for inter- and intraspecific variation in social behaviour. Eur J Neurosci. 2002;16:399–402.Google Scholar
43.Lim, MM, Wang, ZX, Olazabal, DE, Rex, X, Terwilliger, EF, Young, LJ. Enhanced partner preference in a promiscuous species by manipulating the expression of a single gene. Nature. 2004;429:754–757.Google Scholar
44.Hammock, EAD, Young, LJ. Microsatellite instability generates diversity in brain and sociobehavioral traits. Science. 2005;308:1630–1634.Google Scholar
45.Donaldson, ZR, Kondrashov, FA, Putnam, A, et al.Evolution of a behavior-linked microsatellite-containing element in the 5 flanking region of the primate AVPR1A gene. BMC Evol Biol. 2008;8:180.Google Scholar
46.Carter, CS, Pournajafi-Nazarloo, H, Kramer, KM, et al.Oxytocin: Behavioral associations and potential as a salivary biomarker. Ann NY Acad Sci. 2007;1098:312–322.Google Scholar
47.Stein, DJ. Empathy: At the heart of the mind. CNS Spectr. 2005;10:280–283.Google Scholar
48.Stein, DJ, Vythilingum, B. Love and attachment: the psychobiology of social bonding. CNS Spectr. 2009;14:239–242.Google Scholar
49.Stein, DJ. How we see others: the psychobiology of schemas and transference. CNS Spectr. 2009;14:10–13.Google Scholar
50.Bartz, JA, Hollander, E. Oxytocin and experimental therapeutics in autism spectrum disorders. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:451–462.Google Scholar
51.Guastella, AJ, Howard, AL, Dadds, MR, Mitchell, P, Carson, DS. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder. Psychoneuroendocrinology. 2009;34:917–923.Google Scholar
52.Chini, B, Manning, M, Guillon, G. Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an “easy guide” to receptor pharmacology. In: Landgraf, R, Neumann, I, eds. Progress in Brain Research Advances in Vasopressin and Oxytocin–From Genes to Behaviour to Disease. Oxford, UK: Elsevier; 2008:513–517.Google Scholar
53.Scott, LV, Dinan, TG. Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord. 2002;72:113–124.Google Scholar
54.Shimazaki, T, lijima, M, Ito, A, et al.Blockade of vasopressin V1b receptor displays anxiolytic and antidepressant effects in animal models. Journal of Pharmacological Sciences. 2007;103:233P.Google Scholar
55.Adolphs, R. The Social Brain: Neural Basis of Social Knowledge. Annu Rev Psychol. 2009;60:693–716.Google Scholar
56.Swain, JE, Lorberbaum, JP, Kose, S, Strathearn, L. Brain basis of early parent-infant interactions: psychology, physiology, and in vivo functional neuroimaging studies. J Child Psychol Psychiatry. 2007;48:262–287.Google Scholar
57.Zeki, S. The neurobiology of love. FEBS Lett. 2007;581:2575–2579.CrossRefGoogle ScholarPubMed